75 related articles for article (PubMed ID: 26726846)
1. Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice.
Kongpetch S; Puapairoj A; Ong CK; Senggunprai L; Prawan A; Kukongviriyapan U; Chan-On W; Siew EY; Khuntikeo N; Teh BT; Kukongviriyapan V
Cell Prolif; 2016 Feb; 49(1):90-101. PubMed ID: 26726846
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of 14-3-3
Wu Q; Fan H; Lang R; Li X; Zhang X; Lv S; He Q
Biomed Res Int; 2020; 2020():3740418. PubMed ID: 32685476
[TBL] [Abstract][Full Text] [Related]
3. Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract.
Amuamuta A; Plengsuriyakarn T; Na-Bangchang K
BMC Complement Altern Med; 2017 Apr; 17(1):213. PubMed ID: 28403856
[TBL] [Abstract][Full Text] [Related]
4. HO-1 nuclear accumulation and interaction with NPM1 protect against stress-induced endothelial senescence independent of its enzymatic activity.
Luo W; Li J; Li Z; Lin T; Zhang L; Yang W; Mai Y; Liu R; Chen M; Dai C; Yang H; Lu J; Li H; Guan G; Huang M; Liu P; Li Z
Cell Death Dis; 2021 Jul; 12(8):738. PubMed ID: 34312365
[TBL] [Abstract][Full Text] [Related]
5. Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.
Ahmad IM; Dafferner AJ; O'Connell KA; Mehla K; Britigan BE; Hollingsworth MA; Abdalla MY
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066839
[TBL] [Abstract][Full Text] [Related]
6. Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis.
Muliaditan T; Caron J; Okesola M; Opzoomer JW; Kosti P; Georgouli M; Gordon P; Lall S; Kuzeva DM; Pedro L; Shields JD; Gillett CE; Diebold SS; Sanz-Moreno V; Ng T; Hoste E; Arnold JN
Nat Commun; 2018 Jul; 9(1):2951. PubMed ID: 30054470
[TBL] [Abstract][Full Text] [Related]
7. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma.
Ito Y; Yamada D; Kobayashi S; Sasaki K; Iwagami Y; Tomimaru Y; Asaoka T; Noda T; Takahashi H; Shimizu J; Doki Y; Eguchi H
Cancer Lett; 2024 May; ():216997. PubMed ID: 38801887
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma.
Da Z; Gao L; Su G; Yao J; Fu W; Zhang J; Zhang X; Pei Z; Yue P; Bai B; Lin Y; Meng W; Li X
Cancer Cell Int; 2020; 20():130. PubMed ID: 32336950
[TBL] [Abstract][Full Text] [Related]
9. Aurora B facilitates cholangiocarcinoma progression by stabilizing c-Myc.
Liu K; Zhou X; Huang F; Liu L; Xu Z; Gao C; Zhang K; Hong J; Yao N; Cheng G
Animal Model Exp Med; 2024 Jan; ():. PubMed ID: 38247322
[TBL] [Abstract][Full Text] [Related]
10. Cordycepin Enhanced Therapeutic Potential of Gemcitabine against Cholangiocarcinoma via Downregulating Cancer Stem-Like Properties.
Lee HK; Na YJ; Seong SM; Ahn D; Choi KC
Biomol Ther (Seoul); 2024 May; 32(3):369-378. PubMed ID: 38589021
[TBL] [Abstract][Full Text] [Related]
11. Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity.
Khojandi N; Kuehm LM; Piening A; Donlin MJ; Hsueh EC; Schwartz TL; Farrell K; Richart JM; Geerling E; Pinto AK; George SL; Albert CJ; Ford DA; Chen X; Kline J; Teague RM
Cancer Immunol Res; 2021 Feb; 9(2):214-226. PubMed ID: 33303575
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine.
Polidoro MA; Ferrari E; Soldani C; Franceschini B; Saladino G; Rosina A; Mainardi A; D'Autilia F; Pugliese N; Costa G; Donadon M; Torzilli G; Marzorati S; Rasponi M; Lleo A
JHEP Rep; 2024 Jan; 6(1):100910. PubMed ID: 38074504
[TBL] [Abstract][Full Text] [Related]
13. The importance of preclinical models in cholangiocarcinoma.
McGreevy O; Bosakhar M; Gilbert T; Quinn M; Fenwick S; Malik H; Goldring C; Randle L
Eur J Surg Oncol; 2024 Mar; ():108304. PubMed ID: 38653585
[TBL] [Abstract][Full Text] [Related]
14. Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Huyen NT; Prachayasittikul V; Chan-On W
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):397-405. PubMed ID: 27107220
[TBL] [Abstract][Full Text] [Related]
15. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions.
Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA
J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy.
Tan Q; Qin Q; Huang Z; Lian B; Mo Q; Wei C
Breast Cancer Res Treat; 2022 Jun; 193(2):393-403. PubMed ID: 35304903
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Heme Oxygenase 1 in Tumor Progression.
Nitti M; Ivaldo C; Traverso N; Furfaro AL
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34067625
[TBL] [Abstract][Full Text] [Related]
18. Nuclear Localization of Heme Oxygenase-1 in Pathophysiological Conditions: Does It Explain the Dual Role in Cancer?
Mascaró M; Alonso EN; Alonso EG; Lacunza E; Curino AC; Facchinetti MM
Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33440611
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of piperlongumine chemosensitivity by silencing heme oxygenase-1 expression in cholangiocarcinoma cell lines.
Talabnin C; Talabnin K; Wongkham S
Oncol Lett; 2020 Sep; 20(3):2483-2492. PubMed ID: 32782567
[TBL] [Abstract][Full Text] [Related]
20. HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies.
Tracey N; Creedon H; Kemp AJ; Culley J; Muir M; Klinowska T; Brunton VG
Breast Cancer Res Treat; 2020 Feb; 179(3):543-555. PubMed ID: 31705351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
